HCPLive Network

Infectious Agents Cause About One in Six Cancers Worldwide

Wednesday, May 9 (HealthDay News) -- Catherine de Martel, M.D., from the International Agency for Research on Cancer in Lyon, France, and colleagues utilized statistics on estimated cancer incidence in 2008 to calculate the population attributable fraction (PAF) of infectious agents classified as carcinogenic to humans, worldwide and in eight geographic regions. Calculations were based on the prevalence of infection in cancer cases rather than in the general population, when the associations were very strong.

The researchers found that, of the 12.7 million new cancer cases that occurred in 2008, the PAF for infectious agents was 16.1 percent. This represented about two million new cases. The fraction of infection-attributable cancers was higher in less developed countries than in more developed countries (22.9 versus 7.4 percent). Approximately 1.9 million cases of gastric, liver, and cervix uteri cancers were caused by Helicobacter pylori, hepatitis B and C viruses, and human papillomaviruses. Cervix uteri cancer accounted for about half of the infection-related burden of cancer in women, while liver and gastric cancers accounted for more than 80 percent in men. Younger people (<50 years) were affected by approximately 30 percent of infection-attributable cases.

"Around two million cancer cases each year are caused by infectious agents," the authors write. "Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Globally, nearly two million new cancer cases are caused by infectious agents each year, according to a study published online May 9 in The Lancet Oncology.


Copyright © 2012 HealthDay. All rights reserved.


Further Reading
Atherosclerotic internal carotid artery disease is a major contributor to ischemic stroke. Surgeons use a combination of carotid artery and brain imaging to determine if patients have symptomatic carotid stenosis. However, there remains widespread disagreement on the threshold, timing, and best technical approach to carotid revascularization in symptomatic patients.
The FDA has cleared a blood test that can screen patients, especially black women, for coronary heart disease.
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.
Related CE/CME
More Reading